COMPUGEN LTD — Investor Relations & Filings
Filings indexed
556
across all filing types
Latest filing
2002-12-09
Major Shareholding Noti…
Country
US
United States of America
Listing
US
CGEN
Compugen Ltd. is a clinical-stage therapeutic discovery and development company focused on cancer immunotherapy. The company utilizes a proprietary, predictive computational platform powered by artificial intelligence and machine learning to systematically identify novel drug targets and biological pathways. This technology enables the discovery and development of first-in-class and best-in-class therapeutics. Compugen's pipeline consists of immuno-oncology programs, including antibody-based product candidates, which are advanced through preclinical and clinical development stages.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2002 | 2002-12-09 | English | |
| Foreign Filer Report 2002 | 2002-11-19 | English | |
| AUTO-GENERATED PAPER DOCUMENT | 2002-10-15 | English | |
| AUTO-GENERATED PAPER DOCUMENT | 2002-09-12 | English | |
| AUTO-GENERATED PAPER DOCUMENT | 2002-08-20 | English | |
| AUTO-GENERATED PAPER DOCUMENT | 2002-08-08 | English |
Browse filings by year
26 years- 2026 8 filings
- 2025 12 filings
- 2024 14 filings
- 2023 32 filings
- 2022 23 filings
- 2021 14 filings
- 2020 35 filings
- 2019 19 filings
- 2018 31 filings
- 2017 19 filings
- 2016 23 filings
- 2015 14 filings
- 2014 29 filings
- 2013 19 filings
- 2012 21 filings
- 2011 32 filings
- 2010 30 filings
- 2009 44 filings
- 2008 30 filings
- 2007 29 filings
- 2006 16 filings
- 2005 16 filings
- 2004 17 filings
- 2003 13 filings
- 2002 14 filings
- 2001 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2002
14 filings
| |||||
| 11350024 | Major Shareholding Notification 2002 | 2002-12-09 | English | ||
| 11350022 | Foreign Filer Report 2002 | 2002-11-19 | English | ||
| 11350026 | AUTO-GENERATED PAPER DOCUMENT | 2002-10-15 | English | ||
| 11350028 | AUTO-GENERATED PAPER DOCUMENT | 2002-09-12 | English | ||
| 11350029 | AUTO-GENERATED PAPER DOCUMENT | 2002-08-20 | English | ||
| 11350030 | AUTO-GENERATED PAPER DOCUMENT | 2002-08-08 | English | ||
| 11350032 | AUTO-GENERATED PAPER DOCUMENT | 2002-06-11 | English | ||
| 11350034 | AUTO-GENERATED PAPER DOCUMENT | 2002-04-15 | English | ||
| 11350036 | AUTO-GENERATED PAPER DOCUMENT | 2002-04-11 | English | ||
| 11350037 | AUTO-GENERATED PAPER DOCUMENT | 2002-03-07 | English | ||
| 11350039 | Major Shareholding Notification 2002 | 2002-02-14 | English | ||
| 11350041 | SC 13G/A | 2002-02-13 | English | ||
| 11350247 | AUTO-GENERATED PAPER DOCUMENT | 2002-02-11 | English | ||
| 11350043 | AUTO-GENERATED PAPER DOCUMENT | 2002-02-01 | English | ||
|
2001
1 filing
| |||||
| 11350044 | INITIAL FILING | 2001-02-14 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
COMPUGEN LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33979/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33979 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33979 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33979 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33979}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for COMPUGEN LTD (id: 33979)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.